Chemoinformaics analysis of BETA-PELTATIN-A-METHYL-ETHER
| Molecular Weight | 428.437 | nRot | 5 |
| Heavy Atom Molecular Weight | 404.245 | nRig | 26 |
| Exact Molecular Weight | 428.147 | nRing | 5 |
| Solubility: LogS | -4.639 | nHRing | 2 |
| Solubility: LogP | 2.833 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 60.829 |
| nHD | 0 | BPOL | 37.097 |
| QED | 0.673 |
| Synth | 3.736 |
| Natural Product Likeliness | 1.518 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.971 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.784 |
| MDCK | 0.0000359 |
| BBB | 0.028 |
| PPB | 0.954486 |
| VDSS | 1.062 |
| FU | 0.0463435 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.984 |
| CYP2c19-inh | 0.757 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.357 |
| CYP2c9-sub | 0.883 |
| CYP2d6-inh | 0.098 |
| CYP2d6-sub | 0.876 |
| CYP3a4-inh | 0.938 |
| CYP3a4-sub | 0.929 |
| CL | 10.155 |
| T12 | 0.136 |
| hERG | 0.093 |
| Ames | 0.074 |
| ROA | 0.094 |
| SkinSen | 0.144 |
| Carcinogencity | 0.228 |
| EI | 0.081 |
| Respiratory | 0.588 |
| NR-Aromatase | 0.48 |
| Antiviral | Yes |
| Prediction | 0.786415 |